A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ¥27,767.67, with a 24-hour trading volume of ¥89.87B. The asset's market cap is ¥43.06T, after moving 0.08% in the last day.
Tokenized AstraZeneca PLC is trading at ¥15,840.4, with a tokenized market cap of ¥8.96B and a 24-hour trading volume of ¥131.92M. The tokenized asset has moved -3.68% in the past 24 hours.